Technology / SemiconductorsUpdated 2026-05-10 22:07 UTC

BCBA/LRCX stock hub

BCBA/LRCX has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BCBA/LRCXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

512.1T

Buenos Aires Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BCBA/LRCX

In the news

Latest news · BCBA/LRCX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E39.5

P25 17.9P50 25.7P75 51.4

Trailing P/E55.6

P25 19.4P50 29P75 47.7

ROE66.8

P25 8.1P50 32.3P75 36.2

ROIC73.9

P25 10.9P50 27.2P75 52.2

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BCBA/LRCX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

230

Groups with data

Currency

USD

Showing 230 of 230 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	AR
Employees	20,600
Employees Change	1,400%
Employees Change Percent	7.65
Enterprise value	ARS 510.7T
Exchange	Buenos Aires Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Semiconductors
Isin	ARBCOM4603X6
Last refreshed	2026-05-10
Market cap	ARS 512.1T
Price	ARS 7,790
Price currency	ARS
Rev Per Employee	1,445,634,384.08x
Sector	Technology
Sic	3559
Symbol	bcba/LRCX
Website	https://www.lamresearch.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.8%
EV Earnings	55.43x
EV/EBIT	49.37x
EV/EBITDA	45.7x
EV/FCF	61.92x
EV/Sales	16.91x
FCF yield	1.61%
Forward P/E	39.5x
P/B ratio	35.23x
P/E ratio	55.58x
P/S ratio	17.2x
PE Ratio10 Y	19.6x
PE Ratio3 Y	27.92x
PE Ratio5 Y	23.3x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	34.26%
EBITDA Margin	36.2%
FCF margin	27.7%
Gross margin	49.98%
Gross Profit	ARS 14.9T
Gross Profit Growth	31.59%
Gross Profit Growth Q	25.8%
Gross Profit Growth3 Y	8.49%
Gross Profit Growth5 Y	11.92%
Net Income	ARS 9.2T
Net Income Growth	44%
Net Income Growth Q	37.18%
Net Income Growth Quarters	9%
Net Income Growth Years	1%
Net Income Growth3 Y	10.91%
Net Income Growth5 Y	14.15%
Pretax Margin	34.53%
Profit Margin	30.94%
Profit Per Employee	ARS 447.3M
Profitable Years	16
ROA	22.78
Roa5y	17.99
ROCE	47.77
ROE	66.76
Roe5y	62.17
ROIC	73.88
Roic5y	64.79

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	408.9%
Cagr3y	163.31%
Div CAGR3	134.17%
EPS Growth	47.52
EPS Growth Q	40.78
EPS Growth Quarters	9
EPS Growth Years	1
EPS Growth3 Y	13.79
EPS Growth5 Y	17.49
FCF Growth	58.28%
FCF Growth Q	-20.65%
FCF Growth3 Y	14.97%
FCF Growth5 Y	17.6%
OCF Growth	55.19%
OCF Growth Q	-12.78%
OCF Growth10 Y	19.03%
OCF Growth3 Y	15.62%
OCF Growth5 Y	18.59%
Revenue Growth	26.53x
Revenue Growth Q	23.76x
Revenue Growth Quarters	8x
Revenue Growth Years	1x
Revenue Growth3 Y	4.76x
Revenue Growth5 Y	10.31x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	ARS 1.06
Assets	ARS 28.6T
Cash	ARS 6.5T
Current Assets	ARS 18.6T
Current Liabilities	ARS 7.3T
Debt	ARS 5.1T
Debt EBITDA	ARS 0.47
Debt Equity	ARS 0.35
Debt FCF	ARS 0.62
Equity	ARS 14.5T
Interest Coverage	44.89
Liabilities	ARS 14T
Long Term Assets	ARS 10T
Long Term Liabilities	ARS 6.7T
Net Cash	ARS 1.4T
Net Cash By Market Cap	ARS 0.27
Net Cash Growth	5.18%
Net Debt EBITDA	ARS -0.13
Net Debt Equity	ARS -0.1
Net Debt FCF	ARS -0.17
Tangible Book Value	ARS 12T
Tangible Book Value Per Share	ARS 9,558

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.54
Inventory Turnover	2.56
Net Working Capital	ARS 4.5T
Quick ratio	1.69
Working Capital	ARS 11.1T
Working Capital Turnover	ARS 3,717

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	2.5%
Dividend Growth	55.68%
Dividend Growth Years	4%
Dividend per share	ARS 15.47
Dividend Years	5
Dividend Yield	0.2%
Ex Div Date	2026-03-04
Last Dividend	ARS 4.15
Payout Frequency	Quarterly
Payout Ratio	18.49%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	408.33%
200-day SMA	4,628
3Y total return	1,726.85%
50-day SMA	6,338.3
50-day SMA vs 200-day SMA	50over200
All Time High	7,910
All Time High Change	-1.52%
All Time High Date	2026-05-08
All Time Low	172.4
All Time Low Change	4,418.56%
All Time Low Date	2022-10-17
ATR	351.4
Ch YTD	64.87
High	7,910
High52	7,910
High52 Date	2026-05-08
High52ch	-1.27%
Low	7,685
Low52	1,515
Low52 Date	2025-05-09
Low52ch	414.19%
Ma50ch	22.9%
Price vs 200-day SMA	68.32%
RSI	65.33
RSI Monthly	84.43
RSI Weekly	76.22
Sharpe ratio	3.16x
Sortino ratio	5.26
Total Return	2.69%
Tr YTD	65.06
Tr1m	31.15%
Tr1w	12.74%
Tr3m	26.81%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	ARS 10.2T
Operating Income Growth	40.38
Operating Income Growth Q	31.07
Operating Income Growth3 Y	7.94
Operating Income Growth5 Y	13.62
Operating margin	34.26

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,245,503,174%
Net Borrowing	-1,056,767,178,452.7
Shares Insiders	0.28%
Shares Institutions	85.29%
Shares Qo Q	-0.35%
Shares Yo Y	-2.5%
Short Ratio	2.61

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	ARS 7.7T
Average Volume	31,007.7x
Bv Per Share	11,625.6
CAPEX	ARS -1.3T
Ch1m	31.15
Ch1w	12.74
Ch1y	405.8
Ch3m	26.67
Ch3y	1,700.9
Ch6m	86.7
Change	2.5%
Change From Open	1.37
Close	7,600
Days Gap	1.12
Depreciation Amortization	587,897,882,252.6
Dollar Volume	78,982,810
Earnings Date	2026-07-30
EBIT	ARS 10.2T
EBITDA	ARS 10.8T
EPS	ARS 7,272
F Score	7
FCF	ARS 8.2T
FCF EV Yield	1.61x
Financing CF	-9,267,041,970,038
Fiscal Year End	June
Founded	1,980
Graham Number	835.05489
Graham Upside	-89.28
Income Tax	ARS 1.1T
Investing CF	-1,246,676,026,155
Is Primary Listing	0
Last Earnings Date	2026-01-28
Last Report Date	2026-03-29
Last Split Date	2024-10-03
Last Split Type	Forward
Lynch Fair Value	ARS 1,984
Lynch Upside	-74.53
Ma150	5,316.4
Ma150ch	46.53%
Ma20	7,034.3
Ma20ch	10.74%
Net CF	-956,165,138,878
Next Earnings Date	2026-07-30
Open	7,685
P FCF Ratio	62.1
P OCF Ratio	53.61
Payment Date	2026-04-08
Position In Range	46.67
Ppne	3,991,229,813,162
Price Date	2026-05-08
Price EBITDA	ARS 47.51
Ptbv Ratio	42.85
Relative Volume	0.32x
Revenue	29,780,068,312,113x
SBC By Revenue	1.74x
Share Based Comp	517,373,668,705
Tax By Revenue	3.59x
Tax Rate	10.39%
Tr6m	87.1%
Volume	10,139
Z Score	15.27

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

BCBA/LRCX dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.2%

$15.5 annual per share

Payout ratio

+18.5%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

4 consecutive years of growth

Total shareholder yield

+2.7%

Next ex-dividend date: 2026-03-04

Performance

BCBA/LRCX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BCBA/LRCX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+85.3%

Share of float held by funds and institutions

Insider ownership

+0.3%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

BCBA/LRCX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

65.3

Neutral momentum band

Price vs 200-day MA

+68.3%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

3.16

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BCBA/LRCX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bcba/LRCX stock rating?

bcba/LRCX is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bcba/LRCX analysis?

The full report lives at /stocks/bcba/LRCX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bcba/LRCX?

The latest report frames bcba/LRCX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bcba/LRCX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.